MedTrace Logo

Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma

NCT00201279 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2005-09-20

No results posted yet for this study

Summary

The purpose of this study is to study the effect of 13-cis retinoic acid in preventing second primary malignancy in the oral cavity cancer patients after curative local treatment and to study the toxicity and compliance of 13-cis retinoic acid.

Conditions

Interventions

DRUG

13-cis Retino Acid

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Changhua Christian Hospital

    collaborator OTHER

  • China Medical University Hospital

    collaborator OTHER

  • Buddhist Tzu Chi General Hospital

    collaborator OTHER

  • Taichung Veterans General Hospital

    collaborator OTHER

  • Mackay Memorial Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Koo Foundation Sun Yat-Sen Cancer Center

    collaborator OTHER

  • Chi Mei Medical Hospital

    collaborator OTHER

  • National Cheng-Kung University Hospital

    collaborator OTHER

  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Mow-Ming Hsu, MD · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-04-30
Completion
2012-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201279 on ClinicalTrials.gov